Some studies have demonstrated that FGL2 is expressed in human gliomas, and its expression is involved in the malignant transformation from low-grade gliomas (LGGs) to high-grade gliomas (HGGs), which indicates that the expression level of FGL2 is related to the grade of gliomas 72. The gene discussed is FGL2; the disease is central nervous system cancer.